Home › Funds › Avidity Partners Management LP › ORKA

Avidity Partners Management LP position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Avidity Partners Management LP reported holding 760,424 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$72.4M, representing 11.59% of its reported portfolio and ranking #3 among its reported holdings. Avidity Partners Management LP has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)760.42K sh
Reported value held$72.37M
Portfolio Weight11.59%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's ORKA position evolved

Avidity Partners Management LP first disclosed a stake in ORKA in Q3 2024 at 790,926 shares (US$19.4M). The position peaked in Q2 2026 at 760,424 shares, worth US$72.4M. Across 8 filings, Avidity Partners Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 760,424 shares valued at US$72.4M. Notable position changes include a 55% trim in Q4 2024 (shares fell 47% over the following quarter), a 88% increase in Q3 2025 (shares rose 58% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 790.93K $19.39M New
Q4 2024 352.12K $6.83M Reduce
Q1 2025 352.12K $3.61M Hold
Q2 2025 352.12K $3.95M Hold
Q3 2025 660.42K $12.70M Add
Q4 2025 660.42K $20.02M Hold
Q1 2026 760.42K $37.30M Add
Q2 2026 760.42K $72.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Avidity Partners Management LP held ORKA?

Avidity Partners Management LP has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Avidity Partners Management LP's current position in ORKA?

As of Q2 2026, Avidity Partners Management LP holds 760.42K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $72.37M, representing 11.59% of its reported portfolio and ranking #3.

Has Avidity Partners Management LP been buying or selling ORKA?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP held unchanged its position in ORKA. The position peaked in Q2 2026 at 760.42K shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.